Opthea Competitors and Similar CompaniesClear all
Novartis's competitors and similar companies include Santen, Ocular Therapeutix and Genentech.
 Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Ocular Therapeutix Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology. |  Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. | ||
Founding Date | Founding Date 1996 | Founding Date 1890 | Founding Date 2006 | Founding Date 1976 |
Type | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Bedford, US HQ Bedford, US Bedford, US | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more | |
Employees | Employees 75,883 | Employees 3,744 | Employees 16740% increase | Employees 18,077 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 4.1 b | Valuation ($) 1.8 b | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $52m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $8.4b (FY, 2025) | Cost of goods N/A | Cost of goods $6.6m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $49.8b (FY, 2025) | Gross profit N/A | Gross profit $45.4m (FY, 2025) | Gross profit N/A |
Net income | Net income $14b (FY, 2025) | Net income N/A | Net income ($265.9m) (FY, 2025) | Net income N/A |
Operating ⚠ | ||||
Phase III Trials Products | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 41 (Jul, 2025) |
Funding | ||||
Total funding raised | Total funding raised $ 6.5m | Total funding raised $ 74.4m | Total funding raised $ 73.3m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Santen
HQ
Osaka, JP
Employees
3,744
Santen is a specialized pharmaceutical company focusing on ophthalmology.
View companyOcular Therapeutix
HQ
Bedford, US
Employees
167↑ 40% increase
Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.
View companyGenentech
HQ
South San Francisco, US
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View company